Hanlin Gao - Feb 15, 2023 Form 4 Insider Report for Fulgent Genetics, Inc. (FLGT)

Role
Chief Scientific Officer
Signature
/s/ Paul Kim as Attorney-in-Fact
Stock symbol
FLGT
Transactions as of
Feb 15, 2023
Transactions value $
-$13,018
Form type
4
Date filed
2/17/2023, 04:00 PM
Previous filing
Feb 1, 2023
Next filing
Feb 27, 2023
SEC
View on sec.gov

Transactions Table

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on August 1, 2019, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on August 5, 2019.